Understanding immune responses to develop vaccines and treatments for infectious diseases
NIH TETRAMER CORE FACILITY (INFECTIOUS DISEASES OTHER THAN HIV/AIDS)
This study is all about learning how our immune system fights infections, which can help create better vaccines and treatments for everyone, and it provides important tools to scientists around the world to help them in their research.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-10589010 on NIH RePORTER |
What this research studies
This research focuses on enhancing our understanding of how the immune system responds to infectious diseases, which is crucial for developing effective vaccines and therapeutic agents. The project supports a facility that synthesizes and distributes specialized reagents, known as MHC tetramers, to researchers worldwide. These reagents help scientists study immune responses in detail, ultimately aiming to improve public health outcomes. Patients may benefit indirectly through advancements in treatments and vaccines that arise from this research.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals affected by various infectious diseases or those at risk of such conditions.
Not a fit: Patients with non-infectious diseases or those not involved in the immune response may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new vaccines and therapies that improve prevention and treatment of infectious diseases.
How similar studies have performed: Other research has shown success in using similar approaches to enhance vaccine development and improve immune response understanding.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Altman, John — Emory University
- Study coordinator: Altman, John
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.